Related references
Note: Only part of the references are listed.PI3K-mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models
Fan Lin et al.
CLINICAL CANCER RESEARCH (2017)
The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma
Jing Wang et al.
JOURNAL OF CELL SCIENCE (2017)
Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells
Hui K. Gan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Richard Hill et al.
NATURE COMMUNICATIONS (2017)
Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion
Yangyang Xu et al.
ONCOTARGET (2017)
Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
Nichola Cruickshanks et al.
CANCERS (2017)
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells
D. Maciaczyk et al.
BRITISH JOURNAL OF CANCER (2017)
The NF1 somatic mutational landscape in sporadic human cancers
Charlotte Philpott et al.
HUMAN GENOMICS (2017)
PLOD2 in cancer research
Hongzhi Du et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis
Reem Malek et al.
CANCER RESEARCH (2017)
Role of Proton Pumps in Tumorigenesis
V. A. Kobliakov
BIOCHEMISTRY-MOSCOW (2017)
Hypoxia-Mediated Mechanisms Associated with Antiangiogenic Treatment Resistance in Glioblastomas
Sean Mahase et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells
Richard E. Kast et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
EGFRvIII/integrin β3 interaction in hypoxic and vitronectin-enriching microenvironment promote GBM progression and metastasis
Zhaoyu Liu et al.
ONCOTARGET (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Hypoxia-inducible factor 3 biology: complexities and emerging themes
Cunming Duan
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models
I. A. Netland et al.
BMC CANCER (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Inhibition of carbonic anhydrase IX in glioblastoma multiforme
Abdolali Amiri et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
FAT1 is a novel upstream regulator of HIF1 and invasion of high grade glioma
Evanka Madan et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation
Qi Xie et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
Laura Mercurio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis
Ying Wang et al.
ONCOLOGY REPORTS (2016)
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
Stephanie Anais Castaldo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma
Dong-ye Mao et al.
ONCOTARGET (2016)
Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation
Yamato Tanabe et al.
ONCOTARGET (2016)
Maraviroc decreases CCL8-mediated migration of CCR5+ regulatory T cells and reduces metastatic tumor growth in the lungs
E. C. Halvorsen et al.
ONCOIMMUNOLOGY (2016)
Hallmarks of glioblastoma: a systematic review
Dorte Schou Noroxe et al.
ESMO OPEN (2016)
Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion
Lanfu Zhao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres
Ulf D. Kahlert et al.
BRAIN PATHOLOGY (2015)
Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis
Justin V. Joseph et al.
CANCER LETTERS (2015)
Twist predicts poor outcome of patients with astrocytic glioma
Kristiina Nordfors et al.
JOURNAL OF CLINICAL PATHOLOGY (2015)
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Wenchao Zhou et al.
NATURE CELL BIOLOGY (2015)
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525
Meihua Wang et al.
NEURO-ONCOLOGY (2015)
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma
Matthias Bache et al.
ONCOLOGY REPORTS (2015)
Gene expressions of TRP channels in glioblastoma multiforme and relation with survival
M. Alptekin et al.
TUMOR BIOLOGY (2015)
Role of tenascins in the ECM of gliomas
Nicole Broesicke et al.
CELL ADHESION & MIGRATION (2015)
LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
Roseli da Silva et al.
PLOS ONE (2015)
The potential to target CCL5/CCR5 in breast cancer
Marco Velasco-Velazquez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
HSP27,70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)
Xiaoxia Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral nnicroenvironment and is predictive of patient outcome
Randy L. Jensen et al.
NEURO-ONCOLOGY (2014)
Angiogenesis and expression of PDGF-C, VEGF, CD105 and HIF-1 alpha in human glioblastoma
Carlos Afonso Clara et al.
NEUROPATHOLOGY (2014)
Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice
E. Serres et al.
ONCOGENE (2014)
Multilayer control of the EMT master regulators
H. Zheng et al.
ONCOGENE (2014)
Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
Lin-Fang Wang et al.
ONCOLOGY REPORTS (2014)
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Hypoxia-Inducible Factor 3 Is an Oxygen-Dependent Transcription Activator and Regulates a Distinct Transcriptional Response to Hypoxia
Peng Zhang et al.
CELL REPORTS (2014)
Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
Liliana Soroceanu et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
Florian A. Siebzehnrubl et al.
EMBO MOLECULAR MEDICINE (2013)
Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells
Craig E. Barcus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Geranylgeranyltransferase I regulates HIF-1 alpha promoting glioblastoma cell migration and invasion
Xiuping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group
Tobey J. MacDonald et al.
NEURO-ONCOLOGY (2013)
Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model
Patrick N. Harter et al.
NEUROPATHOLOGY (2013)
Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
T. S. Karin Eisinger-Mathason et al.
CANCER DISCOVERY (2013)
Cyclin G2 Promotes HypoxiaDriven Local Invasion of Glioblastoma by Orchestrating Cytoskeletal Dynamics
Atsushi Fujimura et al.
NEOPLASIA (2013)
Deregulated Signaling Pathways in Glioblastoma Multiforme: Molecular Mechanisms and Therapeutic Targets
Hua Mao et al.
CANCER INVESTIGATION (2012)
Antitumor Activity of NVP-BKM120-A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
Dimpy Koul et al.
CLINICAL CANCER RESEARCH (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
Liuqi Yang et al.
EXPERIMENTAL CELL RESEARCH (2012)
Cadherin-11, a Marker of the Mesenchymal Phenotype, Regulates Glioblastoma Cell Migration and Survival In Vivo
Harpreet Kaur et al.
MOLECULAR CANCER RESEARCH (2012)
Function of carbonic anhydrase IX in glioblastoma multiforme
Martin A. Proescholdt et al.
NEURO-ONCOLOGY (2012)
Current clinical development of PI3K pathway inhibitors in glioblastoma
Patrick Y. Wen et al.
NEURO-ONCOLOGY (2012)
Berberine Inhibits Pulmonary Metastasis through Down-regulation of MMP in Metastatic B16F-10 Melanoma Cells
T. P. Hamsa et al.
PHYTOTHERAPY RESEARCH (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
Novel Cryo-Imaging of the Glioma Tumor Microenvironment Reveals Migration and Dispersal Pathways in Vivid Three-Dimensional Detail
Susan M. Burden-Gulley et al.
CANCER RESEARCH (2011)
In Vivo Profiling of Hypoxic Gene Expression in Gliomas Using the Hypoxia Marker EF5 and Laser-capture Microdissection
Diane Marotta et al.
CANCER RESEARCH (2011)
Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis
Esmeralda Casas et al.
CANCER RESEARCH (2011)
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
Joerg Felsberg et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion
Udhayakumar Gopal et al.
PLOS ONE (2011)
Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review
Paolo E. Porporato et al.
FRONTIERS IN PHARMACOLOGY (2011)
Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres
Eli E. Bar et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
SNAI2/Slug promotes growth and invasion in human gliomas
Hong Wei Yang et al.
BMC CANCER (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Receptor Channel TRPC6 Is a Key Mediator of Notch-Driven Glioblastoma Growth and Invasiveness
Srinivasulu Chigurupati et al.
CANCER RESEARCH (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres
Olga Mendez et al.
MOLECULAR CANCER (2010)
TWIST1 promotes invasion through mesenchymal change in human glioblastoma
Svetlana A. Mikheeva et al.
MOLECULAR CANCER (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
INHIBITION OF TISSUE FACTOR/PROTEASE-ACTIVATED RECEPTOR-2 SIGNALING LIMITS PROLIFERATION, MIGRATION AND INVASION OF MALIGNANT GLIOMA CELLS
F. Gessler et al.
NEUROSCIENCE (2010)
TWISTing an embryonic transcription factor into an oncoprotein
S. Ansieau et al.
ONCOGENE (2010)
Tissue Factor and PAR2 Signaling in the Tumor Microenvironment
Florence Schaffner et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
αvβ3/αvβ5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Nicolas Skuli et al.
CANCER RESEARCH (2009)
The Mechanical Rigidity of the Extracellular Matrix Regulates the Structure, Motility, and Proliferation of Glioma Cells
Theresa A. Ulrich et al.
CANCER RESEARCH (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
Mohamed Abdouh et al.
JOURNAL OF NEUROSCIENCE (2009)
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis
Balasubramaniam Annamalai et al.
MOLECULAR CANCER RESEARCH (2009)
NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas
Ta-Jen Liu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
TWIST activation by hypoxia inducible factor-1 (HIF-1)
Muh-Hwa Yang et al.
CELL CYCLE (2008)
Mitochondrial complex III regulates hypoxic activation of HIF
T. Klimova et al.
CELL DEATH AND DIFFERENTIATION (2008)
Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy
Jill Wykosky et al.
CLINICAL CANCER RESEARCH (2008)
Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection
Sharon S. Lieberman-Blum et al.
CLINICAL THERAPEUTICS (2008)
Amentoflavone Inhibits Experimental Tumor Metastasis Through a Regulatory Mechanism Involving MMP-2, MMP-9, Prolyl Hydroxylase, Lysyl Oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and Cytokines in Lung Tissues of C57BL/6 Mice
Chandrasekaran Guruvayoorappan et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2008)
Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes
Mika Hilvo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric brain tumor consortium study PBTC-012
Tobey J. MacDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Sauveur-Michel Maira et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Tissue factor and protease-activated receptor signaling in cancer
Florence Schaffner et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma
Tim F. Cloughesy et al.
PLOS MEDICINE (2008)
Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro
Harun M. Said et al.
ONCOLOGY REPORTS (2008)
β-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells
C. Guruvayoorappan et al.
INTEGRATIVE CANCER THERAPIES (2007)
Angiogenesis in brain tumours
Rakesh K. Jain et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Inhibitors of the heat shock response: Biology and pharmacology
Marissa V. Powers et al.
FEBS LETTERS (2007)
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis
Brian T. Ragel et al.
NEUROSURGICAL REVIEW (2007)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1α in human glioma in vitro and in vivo
Harun M. Said et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1α and mediates its destabilization in a VHL-independent manner
Daniela Fluegel et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion
David Zagzag et al.
LABORATORY INVESTIGATION (2006)
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms
Yuan Rong et al.
CANCER RESEARCH (2006)
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
Xin Hong et al.
CANCER LETTERS (2006)
CXCR4 expression mediates glioma cell invasiveness
M Ehtesham et al.
ONCOGENE (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Yuan Rong et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Vessel tortuosity and brain tumor malignancy: A blinded study
E Bullitt et al.
ACADEMIC RADIOLOGY (2005)
EphA2 as a novel molecular marker and target in glioblastoma multiforme
J Wykosky et al.
MOLECULAR CANCER RESEARCH (2005)
TWIST is expressed in human gliomas and promotes invasion
MC Elias et al.
NEOPLASIA (2005)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Signaling of the tissue factor coagulation pathway in angiogenesis and cancer
M Belting et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A conditional feedback loop regulates Ras activity through EphA2
M Macrae et al.
CANCER CELL (2005)
Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: Implications for collagen cross-linking and treatment of fibrosis
AM Zuurmond et al.
MATRIX BIOLOGY (2005)
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
B Kaur et al.
NEURO-ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma
Y Rong et al.
CANCER RESEARCH (2005)
Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma
DJ Brat et al.
LABORATORY INVESTIGATION (2004)
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
DJ Brat et al.
CANCER RESEARCH (2004)
Multiple connections link FAK to cell motility and invasion
DD Schlaepfer et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
The biology and clinical relevance of the PTEN tumor suppressor pathway
I Sansal et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation
LA Timmerman et al.
GENES & DEVELOPMENT (2004)
Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance
KD Aldape et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Oxygen sensing by HIF hydroxylases
CJ Schofield et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis
AJ van der Slot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hypoxia-inducible factor and its biomedical relevance
LE Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of the repulsive receptor Roundabout inhibits N-cadherin-mediated cell adhesion
J Rhee et al.
NATURE CELL BIOLOGY (2002)
Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B′ subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest
DA Bennin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
A Twist in fate: evolutionary comparison of Twist structure and function
I Castanon et al.
GENE (2002)
FIH-1:: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity
PC Mahon et al.
GENES & DEVELOPMENT (2001)
Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
K Clarke et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor
LO Gerlach et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation
H Miao et al.
NATURE CELL BIOLOGY (2000)
Share Paper
